The global healthcare industry experienced a 12% drop in new job postings related to artificial intelligence in Q3 2022 compared with the previous quarter, according to GlobalData’s whitepaper on Artificial Intelligence in Healthcare – Hiring Activity in Q3 2022. This compares to an 11% increase versus Q3 2021.
Notably, Software and Web Developers, Programmers, and Testers jobs accounted for a 20% share of the global healthcare industry’s artificial intelligence-related total new job postings in Q3 2022, down 6% over the prior quarter.
Software and Web Developers, Programmers, and Testers, with a share of 20%, emerged as the top artificial intelligence-related job roles within the healthcare industry in Q3 2022, with new job postings drop by 6% quarter-on-quarter. Data Scientists came in second with a share of 6% in Q3 2022, with new job postings drop by 16% over the previous quarter.
The other prominent artificial intelligence roles include Database and Network Administrators and Architects with a 5% share in Q3 2022, General and Operations Managers with a 4% share of new job postings.
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q3 2022 were Accenture, International Business Machines, Cognizant Technology Solutions and UnitedHealth Group. Together they accounted for a combined share of 23% of all artificial intelligence-related active jobs in the healthcare industry.
Accenture posted 1,646 jobs in Q3 2022 and registered a drop of 21% over the previous quarter, followed by International Business Machines with 948 jobs and a 55% drop. Cognizant Technology Solutions with 906 jobs and UnitedHealth Group with 464 jobs, recorded a 104% growth and a 13% decrease, respectively, while Weill Cornell Medical College recorded a 20% decline with 450 job postings during Q3 2022.
The largest share of artificial intelligence-related new job postings in the healthcare industry in Q3 2022 was in the US with 64% followed by India (12%) and Canada (3%). The share represented by the US was six percentage points higher than the 58% share it accounted for in Q2 2022.